Skip to main content
. 2016 Jun 27;8(25):40152–40168. doi: 10.18632/oncotarget.10308

Table 1. Quantification of Olaparib sensitivities (IC50) and RAD51 foci in EOC cell lines.

IC50 Olaparib (µM) RAD51 foci fold change
Resistant OV1369 (R2) 21.71 ± 10.33 4.5 ± 0.30
TOV1369 9.02 ± 3.66 2.0 ± 0.05
OV866(2) 8.11 ± 1.27 2.71 ± 0.21
OV90 7.04 ± 2.33 3.80 ± 0.23
Intermediate TOV2223G 2.99 ± 1.20 2.11 ± 0.08
TOV3133D 2.00 ± 1.15 1.53 ± 0.1
OV2295(R2) 1.66 ± 0.99 2.01 ± 0.1
TOV3291G 1.58 ± 0.23 1.64 ± 0.3
TOV2295(R) 1.52 ± 1.14 2.23 ± 0.29
OV4485 0.90 ± 0.58 0.82 ± 0.2
OV3133(R) 0.75 ± 0.04 1.05 ± 0.05
TOV3133G 0.58 ± 0.44 1.37 ± 0.22
TOV2978G 0.45 ± 0.30 1.85 ± 0.23
Sensitive OV1946 0.07 ± 0.05 1.15 ± 0.11
TOV3041G 0.02 ± 0.01 2.05 ± 0.04
TOV1946 0.02 ± 0.007 1.35 ± 0.098
OV4453 0.01 ± 0.0009 1.03 ± 0.067
OV2295 0.0003 ± 0.0004 1.30 ± 0.2